Patient Experience in Systemic Lupus Erythematosus: Development of Novel Patient-Reported Symptom and Patient-Reported Impact Measures

February 2018 in “ Journal of Patient-Reported Outcomes ”

Susan D. Mathias, Pamela Berry, JE de Vries, Katie Pascoe, Hilary H. Colwell, David J. Chang, Anca Askanase

TLDR New tools were created to help lupus patients report their symptoms and impacts more accurately.

The study developed new patient-reported outcome (PRO) measures for systemic lupus erythematosus (SLE) to better capture patient experiences. It involved 42 patients in qualitative interviews to identify key symptoms and impacts, and 20 patients in cognitive interviews to refine the measures. The resulting tools, the SLE Symptom Severity Diary (SSD) and the SLE Impact Questionnaire (SIQ), were designed to be clear, comprehensive, and relevant, with short recall periods to accurately report symptom fluctuations. These tools aimed to improve the accuracy of patient-reported outcomes in clinical trials and practice, enhancing patient care and treatment evaluation.

View this study on jpro.springeropen.com →

Discuss this study in the Community →

Similar Research

6 / 1000+ results

research Rash from EGFR Inhibitors: Opportunities and Challenges for Palliation

18 citations , July 2008 in “Current Oncology Reports”

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

research Rash Morphology as a Predictor of COVID-19 Severity: A Systematic Review of the Cutaneous Manifestations of COVID-19

7 citations , May 2022 in “Skin health and disease”

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

research Managing Hyperglycemia and Rash Associated With Alpelisib: Expert Consensus Recommendations Using the Delphi Technique

1 citations , January 2024 in “NPJ breast cancer”

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

research Research on the Correlation Between Rash and Complement C3, C4 Levels and the Occurrence and Development of Lupus Nephritis

June 2024 in “Research Square (Research Square)”

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

research Clinical Analysis of Rash in Systemic Lupus Erythematosus

February 2018 in “Chin J Clinicians(Electronic Edition)”

Rash in SLE patients indicates more severe disease.

research Non-Rash Skin Toxicities Associated with Novel Targeted Therapies

28 citations , December 2006 in “Clinical lung cancer”

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Patient Experience in Systemic Lupus Erythematosus: Development of Novel Patient-Reported Symptom and Patient-Reported Impact Measures

Related Community Posts Join

community Hives/Rash from Kx 826 Pyrilutamide???

community Suddenly developed rash after 3-years Kirkland minoxidil Foam use. Changed ingredients?

community Is anyone else allergic to Minoxidil

community Only Minoxidil 2 Months Before After Photos

community minoxidil and tretinoin usage

community Women complaining of bad effects from Winlevi (Clascoterone 1%)